Compare DexCom, Inc. (DXCM) vs VanEck Semiconductor ETF (SMH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs VanEck Semiconductor ETF — how do they compare? DexCom, Inc. trades at $78.48 (market cap $28.06B), while VanEck Semiconductor ETF trades at $575.42. Which is the better fit depends on your goals.
| DXCM | SMH | |
|---|---|---|
Market Cap | $28.06B | — |
Sector | Health | — |
52-Week High | $89.53 | $668.91 |
52-Week Low | $54.84 | $283.95 |
Enterprise Value | $27.03B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
SMH (VanEck Semiconductor ETF) trades at $574.81, down 4.19% amid a sector-wide selloff. Technical indicators show a bearish trend with resistance at $588 and support at $576. The ETF has gained 66.69% year-to-date but faces pressure from recent semiconductor weakness. News highlights SMH as a key AI infrastructure play with diversification benefits across chip designers and equipment makers.
Outlook remains tied to semiconductor cycle dynamics—AI demand supports long-term growth, but high valuations and crowded positioning pose near-term risks. Investors face volatility from memory price swings and geopolitical tensions, though SMH offers diversified exposure to the essential chip sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About VanEck Semiconductor ETF
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →
